NCT02980068View on ClinicalTrials.gov

A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

February 25, 2022

Study Completion Date

February 25, 2022

Conditions
Pulmonary; HypertensionHeart FailurePreserved Ejection Fraction
Interventions
DRUG

15N Nitrate

1,000 mg/11.8 mmol, oral, on day one, hour zero

DRUG

14N Nitrate

1,000 mg/11.18 mmol, oral, on day hour, hour zero

Trial Locations (2)

15213

Nydia Chien, Pittsburgh

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Gladwin, Mark, MD

INDIV

NCT02980068 - A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter